AWH - Aspira Women's Health Inc.
IEX Last Trade
0.751
-0.009 -1.198%
Share volume: 0
Last Updated: Thu 26 Dec 2024 04:22:04 PM CET
Surgical and Medical Instrument Manufacturing :
1.37%
PREVIOUS CLOSE
CHG
CHG%
$0.76
-0.01
-1.18%
Fundamental analysis
38%
Profitability
50%
Dept financing
26%
Liquidity
30%
Performance
30%
Performance
5 Days
0.26%
1 Month
2.95%
3 Months
-3.48%
6 Months
-38.24%
1 Year
-73.29%
2 Year
142.92%
Key data
Stock price
$0.75
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.75 - $5.65
52 WEEK CHANGE
-$79.52
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
Company detail
CEO: Nicole Sandford
Region: US
Website: aspirawh.com
Employees: 110
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: aspirawh.com
Employees: 110
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Aspira Women's Health Inc. engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVAInherit tests to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of Gynecologic cancer.
Recent news